SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Indo US Bio-Tech jumps on inking MoU with ICAR-IARI

10 Jul 2025 Evaluate

Indo US Bio-Tech is currently trading at Rs. 157.40, up by 3.90 points or 2.54% from its previous closing of Rs. 153.50 on the BSE.

The scrip opened at Rs. 157.25 and has touched a high and low of Rs. 158.20 and Rs. 153.45 respectively. So far 1729 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 386.00 on 11-Dec-2024 and a 52 week low of Rs. 137.60 on 07-May-2025.

Last one week high and low of the scrip stood at Rs. 159.90 and Rs. 149.00 respectively. The current market cap of the company is Rs. 315.62 crore.

The promoters holding in the company stood at 70.17%, while Non-Institutions held 29.83% stake in the company.

Indo US Bio-Tech has signed Memorandum of Understanding (M0U) with ICAR-IARI for the maize hybrid HQPM-5 variety on July 9, 2025. This collaboration strengthens its commitment to bring high-quality and high-yielding seed varieties to farmers across the country.

Indo US Bio-Tech is engaged in the business of breeding products, processing and marketing of high performing open-pollinated and hybrid agricultural seed varieties & (seed testing, soil & water testing).

Indo US Bio-Tech Share Price

106.61 -0.57 (-0.53%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Venkys India 1478.75
Mangalam Global Ent 12.55
Kaveri Seed 927.05
Regaal Resources 78.46
Simran Farms 156.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×